Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 20, 2026

Zacks Industry Outlook Highlights The Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Vita Coco

View original at finance.yahoo.com
Zacks Industry Outlook Highlights The Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Vita Coco For Immediate Release Chicago, IL – February 20, 2026 – Today, Zacks Equity Research discusses The Coca-Cola Co…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Industry leaders like The Coca-Cola Co., PepsiCo Inc., Monster Beverage Corp., Keurig Dr Pepper Inc. and Vita Coco are well-positioned to outperform by advancing innovation and digital capabilities despite ongoing cost and tariff pressures

    80% confidence
  • PepsiCo expects to benefit from delivering convenience, variety and value proposition to customers through its brands

    80% confidence
  • The company looks well-poised for growth, driven by its ability to drive the brand volume increase via strong retail execution and creative marketing programs

    80% confidence
  • The Zacks Beverages - Soft Drinks industry is gaining momentum as health-focused innovation and digital transformation reshape the landscape

    80% confidence
  • Vita Coco's focus on growing the coconut water category resulted in its overall sales growth, witnessing a 15% CAGR for the last four years

    80% confidence
  • The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1

    80% confidence
  • Monster Beverage management is optimistic about the strength in the global energy drinks category

    80% confidence
  • For the beverage business, PEP expects strong growth and market share gains from the liquid refreshment beverage category, with share gains in the carbonated soft drinks, RTD Tea and water categories

    80% confidence
  • The Soft Drinks industry is contending with mounting pressures as elevated input costs and tariff uncertainty squeeze margins and complicate production planning

    80% confidence
  • KO has been witnessing a splurge in e-commerce, with the growth rate of the channel doubling in many countries

    80% confidence
  • Coca-Cola is poised to gain from strategic transformation and ongoing worldwide recovery, with streamlining of its portfolio and accelerating investments to expand digital presence positioning the company for long-term growth

    80% confidence
  • Rising demand for natural, low-sugar and functional beverages, along with expansion into adjacent categories like RTD alcoholic drinks, is fueling growth

    80% confidence
  • KDP is poised to gain from continued momentum in the Refreshment Beverages segment and solid market share growth

    80% confidence
  • E-commerce continues to surge, with direct-to-consumer channels, subscription models and rapid-delivery partnerships expanding market reach

    80% confidence
  • The industry currently carries a Zacks Industry Rank #84, which places it in the top 35% of more than 250 Zacks industries, indicating bright near-term prospects

    80% confidence
  • The U.S. soft drinks industry is undergoing a rapid transformation as consumers increasingly prioritize health and wellness

    80% confidence
  • MNST has been experiencing continued strength in its energy drinks category, which is driving its performance

    80% confidence

Data points we hold from this source

The Coca-Cola Company · sales growth estimate5.0 percent
The Coca-Cola Company · earnings growth estimate7.7 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Zacks Industry Outlook Highlights The Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Vita Coco — Source | Via News | Via News